Rachel L. Roper
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Rachel L. Roper has a total of 243 co-authors. Here are the top co-authors by number of shared publications:
- Chris Upton
Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC, Canada.
9 shared publications Martin Petric
University of British Columbia Centre for Disease Control, Vancouver, BC V5Z 4R4, Canada
5 shared publicationsR P Phipps
Immunology and Immunotherapy Division of the Cancer Center, Department of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry , Rochester, New York
5 shared publicationsRobert C. Brunham
University of British Columbia Centre for Disease Control, Vancouver, BC V5Z 4R4, Canada
5 shared publicationsGwendolyn J. B. Jones
Department of Microbiology and Immunology, Brody School of Medicine, East Carolina University, Greenville, NC, 27834, USA
4 shared publicationsKristina E. Rehm
East Carolina University, Brody School of Medicine, 600 Moye Blvd, 5E106A, Department of Microbiology & Immunology, Greenville, NC 27834, United States
4 shared publications
Latest Publications
- 13 December 2023
- Published by Elsevier in Environmental Pollution
- Vol. 343, 123164
Comparing and validating air sampling methods for SARS-CoV-2 detection in HVAC ducts of student dorms
- 13 December 2023
- Published by Elsevier in Environmental Pollution
- Vol. 343, 123164
Comparing and validating air sampling methods for SARS-CoV-2 detection in HVAC ducts of student dorms
- Open Access
- 3 July 2023
- Published by Qeios Ltd
Review of: "Behavioral optimization in Scientific Publishing"
This is an excellent and insightful manuscript describing many of the difficulties and disadvantages with the current peer review process and some thoughtful potential courses of action to improve the process. As authors argue, we must give more cre...
- 3 July 2023
- Published by Qeios Ltd
Open AccessReview of: "Behavioral optimization in Scientific Publishing"
This is an excellent and insightful manuscript describing many of the difficulties and disadvantages with the current peer review process and some thoughtful potential courses of action to improve the process. As authors argue, we must give more cre...
- Top Cited PapersOpen Access
- 31 May 2023
- Published by Microbiology Society in Journal of General Virology
- Vol. 104 (5) , 001849
ICTV Virus Taxonomy Profile: Poxviridae 2023
Poxviridae is a family of enveloped, brick-shaped or ovoid viruses. The genome is a linear molecule of dsDNA (128–375 kbp) with covalently closed ends. The family includes the sub-families Entomopoxvirinae, whose members have been found in four orders of insects, and Chordopoxvirinae, whose members are found in mammals, birds, reptiles and fish. Poxviruses are important pathogens in various animals, including humans, and typically result in the formation of lesions, skin nodules, or disseminated rash. Infections can be fatal. This is a summary of the International Committee on Taxonomy of Viruses (ICTV) Report on the family Poxviridae, which is available at ictv.global/report/poxviridae.
- 31 May 2023
- Published by Microbiology Society in Journal of General Virology
- Vol. 104 (5) , 001849
Top Cited PapersOpen AccessICTV Virus Taxonomy Profile: Poxviridae 2023
Poxviridae is a family of enveloped, brick-shaped or ovoid viruses. The genome is a linear molecule of dsDNA (128–375 kbp) with covalently closed ends. The family includes the sub-families Entomopoxvirinae, whose members have been found in four orders of insects, and Chordopoxvirinae, whose members are found in mammals, birds, reptiles and fish. Poxviruses are important pathogens in various animals, including humans, and typically result in the formation of lesions, skin nodules, or disseminated rash. Infections can be fatal. This is a summary of the International Committee on Taxonomy of Viruses (ICTV) Report on the family Poxviridae, which is available at ictv.global/report/poxviridae.
- Open Access
Monkeypox (Mpox) requires continued surveillance, vaccines, therapeutics and mitigating strategies
- Open Access
Waning of SARS-CoV-2 Seropositivity among Healthy Young Adults over Seven Months
Background: We conducted a longitudinal study to estimate immunity produced in response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among university students over seven months. Methods: All participants were attending a public university and resided in Pitt County, North Carolina. University students enrolled weekly for 10 weeks between 26 August 2020 and 28 October 2020, resulting in 136 young adults completing at least one study visit by 17 November 2020. Enrolled students completed an online survey and nasal swab collection at two-week intervals and monthly blood collection between 26 August 2020 and 31 March 2021. Results: Amongst 695 serum samples tested during follow-up, the prevalence of a positive result for anti-nucleocapsid antibodies (N-IgG) was 9.78%. In 22 students with more than one positive N-IgG serum sample, 68.1% of the group lost persistence of N-IgG below the positive threshold over 140 days. Anti-spike IgG antibodies were significantly higher among 11 vaccinated compared to 10 unvaccinated. Conclusions: In healthy young adults, N-IgG wanes below the detectable threshold within five months. S-IgG titer remained consistently elevated months after infection, and significantly increased after vaccination.
Open AccessWaning of SARS-CoV-2 Seropositivity among Healthy Young Adults over Seven Months
Background: We conducted a longitudinal study to estimate immunity produced in response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among university students over seven months. Methods: All participants were attending a public university and resided in Pitt County, North Carolina. University students enrolled weekly for 10 weeks between 26 August 2020 and 28 October 2020, resulting in 136 young adults completing at least one study visit by 17 November 2020. Enrolled students completed an online survey and nasal swab collection at two-week intervals and monthly blood collection between 26 August 2020 and 31 March 2021. Results: Amongst 695 serum samples tested during follow-up, the prevalence of a positive result for anti-nucleocapsid antibodies (N-IgG) was 9.78%. In 22 students with more than one positive N-IgG serum sample, 68.1% of the group lost persistence of N-IgG below the positive threshold over 140 days. Anti-spike IgG antibodies were significantly higher among 11 vaccinated compared to 10 unvaccinated. Conclusions: In healthy young adults, N-IgG wanes below the detectable threshold within five months. S-IgG titer remained consistently elevated months after infection, and significantly increased after vaccination.
- 22 October 2021
- Published by Elsevier in American Journal of Infection Control
- Vol. 50 (3) , 330-335
SARS-CoV-2 Detection in air samples from inside heating, ventilation, and air conditioning (HVAC) systems- COVID surveillance in student dorms
- 22 October 2021
- Published by Elsevier in American Journal of Infection Control
- Vol. 50 (3) , 330-335
SARS-CoV-2 Detection in air samples from inside heating, ventilation, and air conditioning (HVAC) systems- COVID surveillance in student dorms
- 29 January 2021
- Published by Wolters Kluwer Health in Infectious Diseases in Clinical Practice
- Vol. 29 (5) , e287-e293
Discontinuation of Transmission Precautions for COVID-19 Patients
Background: The decision of when it is safe to discontinue transmission-based precautions for SARS-CoV-2 coronavirus disease 2019 (COVID-19) hospitalized patients has been controversial. The Centers for Disease Control and Prevention offered reverse transcriptase polymerase chain reaction (PCR) diagnostic test- or symptom-based guidelines. Methods: A retrospective chart review of Vidant Health system, Eastern North Carolina, was conducted. Length of stay, days in isolation unit, and date appropriate for discharge or isolation discontinuation based on the symptom-based strategy were recorded. Results: Of 196 COVID hospitalized patients, 34 had repeated COVID PCR tests 3 or more days from their first positive test result. Half of these patients experienced delays in release from transmission-based precautions because of repeated positive PCR test results and use of the test-based approach. This resulted in an additional 166 days of hospitalization, costing an estimated $415,000. Furthermore, 2 subjects had a combined 16-day delay in necessary medical procedures. Most of the COVID PCR platforms yield quantitative results in the form of cycle threshold (Ct) values, the number of cycles needed to detect the genome. These values have also been used to assess whether patients are likely to remain contagious. None of our patients who met the criteria for symptom-based strategy for transmission-based precaution discontinuation had positive PCR test results with Ct values lower than 25, but 4 had Ct values lower than 30. Conclusions: Concerns surround immunocompromised patients and those treated with steroids who might be delayed or incapable of stopping viral replication and thus remain contagious. Our results suggest that clinicians use all available data including Ct values to evaluate the safety of discontinuation of transmission precautions.
- 29 January 2021
- Published by Wolters Kluwer Health in Infectious Diseases in Clinical Practice
- Vol. 29 (5) , e287-e293
Discontinuation of Transmission Precautions for COVID-19 Patients
Background: The decision of when it is safe to discontinue transmission-based precautions for SARS-CoV-2 coronavirus disease 2019 (COVID-19) hospitalized patients has been controversial. The Centers for Disease Control and Prevention offered reverse transcriptase polymerase chain reaction (PCR) diagnostic test- or symptom-based guidelines. Methods: A retrospective chart review of Vidant Health system, Eastern North Carolina, was conducted. Length of stay, days in isolation unit, and date appropriate for discharge or isolation discontinuation based on the symptom-based strategy were recorded. Results: Of 196 COVID hospitalized patients, 34 had repeated COVID PCR tests 3 or more days from their first positive test result. Half of these patients experienced delays in release from transmission-based precautions because of repeated positive PCR test results and use of the test-based approach. This resulted in an additional 166 days of hospitalization, costing an estimated $415,000. Furthermore, 2 subjects had a combined 16-day delay in necessary medical procedures. Most of the COVID PCR platforms yield quantitative results in the form of cycle threshold (Ct) values, the number of cycles needed to detect the genome. These values have also been used to assess whether patients are likely to remain contagious. None of our patients who met the criteria for symptom-based strategy for transmission-based precaution discontinuation had positive PCR test results with Ct values lower than 25, but 4 had Ct values lower than 30. Conclusions: Concerns surround immunocompromised patients and those treated with steroids who might be delayed or incapable of stopping viral replication and thus remain contagious. Our results suggest that clinicians use all available data including Ct values to evaluate the safety of discontinuation of transmission precautions.
- 12 January 2021
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 67 (2) , 388-389
The H-Index in Medicine and Science: Does It Favor H-im or H-er? Successes and Hurdles for Women Faculty
- 12 January 2021
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 67 (2) , 388-389
The H-Index in Medicine and Science: Does It Favor H-im or H-er? Successes and Hurdles for Women Faculty
- 20 November 2020
- Published by Wiley in Journal of Medical Virology
- Vol. 93 (6) , 3362-3373
Mosquito‐infecting virus Espirito Santo virus inhibits replication and spread of dengue virus
The primary vector of dengue virus (DENV) is Aedes aegypti. The mosquito‐infecting virus, Espirito Santo virus (ESV), does not infect Vero (mammalian) cells and grows in mosquito (C6/36) cells without cytopathic effects. Effects of ESV infection on replication of DENV were explored in vitro and in vivo, analyzing protein, RNA genome expression, and plaque formation. ESV and DENV simultaneous coinfection did not block protein synthesis from either virus but did result in inhibition of DENV replication in mosquito cells. Furthermore, ESV superinfected with DENV resulted in inhibition of DENV replication and spread in A. aegypti, thus reducing vector competence. Tissue culture experiments on viral kinetics of ESV and DENV coinfection showed that neither virus significantly affects the replication of the other in Vero, HeLa, or HEK cells. Hence, ESV blocks DENV replication in insect cells, but not the mammalian cells evaluated here. Our study provides new insights into ESV‐induced suppression of DENV, a globally important pathogen impacting public health.
- 20 November 2020
- Published by Wiley in Journal of Medical Virology
- Vol. 93 (6) , 3362-3373
Mosquito‐infecting virus Espirito Santo virus inhibits replication and spread of dengue virus
The primary vector of dengue virus (DENV) is Aedes aegypti. The mosquito‐infecting virus, Espirito Santo virus (ESV), does not infect Vero (mammalian) cells and grows in mosquito (C6/36) cells without cytopathic effects. Effects of ESV infection on replication of DENV were explored in vitro and in vivo, analyzing protein, RNA genome expression, and plaque formation. ESV and DENV simultaneous coinfection did not block protein synthesis from either virus but did result in inhibition of DENV replication in mosquito cells. Furthermore, ESV superinfected with DENV resulted in inhibition of DENV replication and spread in A. aegypti, thus reducing vector competence. Tissue culture experiments on viral kinetics of ESV and DENV coinfection showed that neither virus significantly affects the replication of the other in Vero, HeLa, or HEK cells. Hence, ESV blocks DENV replication in insect cells, but not the mammalian cells evaluated here. Our study provides new insights into ESV‐induced suppression of DENV, a globally important pathogen impacting public health.
- Top Cited Papers
- 21 August 2019
- Published by American Society for Microbiology in Microbiology and Molecular Biology Reviews
- Vol. 83 (3)
Does Gender Bias Still Affect Women in Science?
The percentage of women employed in professional scientific positions has been low but is increasing over time. The U.S. National Institutes of Health and the National Science Foundation have both implemented programs to improve women’s participation in science, and many universities and companies have diversity and equity programs.
- 21 August 2019
- Published by American Society for Microbiology in Microbiology and Molecular Biology Reviews
- Vol. 83 (3)
Top Cited PapersDoes Gender Bias Still Affect Women in Science?
The percentage of women employed in professional scientific positions has been low but is increasing over time. The U.S. National Institutes of Health and the National Science Foundation have both implemented programs to improve women’s participation in science, and many universities and companies have diversity and equity programs.